Interpretation of the DECIDE-AI guideline:a reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence
Artificial intelligence has been extensively applied in healthcare services recently,and clinical decision support systems driven by artificial intelligence are one of the applications.Early-stage clinical evaluation of artificial intelligence(AI)-based clinical decision support systems lies between preclinical development(in silico),offline validation,and large-scale trials,but few AI-related clinical studies have addressed human factors evaluations and reported the implementation environment,user characteristics,selection process and algorithm identification of AI systems.In order to bridge the development-to-implementation gap in clinical artificial intelligence and to promote the transparent and standardized reporting of early-stage clinical studies of AI-based decision support systems.A reporting guideline for the developmental and exploratory clinical investigations of decision support systems driven by artificial intelligence(DECIDE-AI)was published in 2022.This paper aimed to interpret the background,development process and key items of the DECIDE-AI guideline and promote its understanding as well as dissemination in China.
Reporting guidelineArtificial intelligenceDecision support systemsEarly-stage clinical evaluationInterpretation
维普
万方数据
